BioSig Technologies, Inc. (BSGM)
OTCMKTS: BSGM · Delayed Price · USD
0.350
0.00 (0.03%)
Jul 2, 2024, 3:58 PM EDT - Market closed
BioSig Technologies Market Cap
BioSig Technologies has a market cap or net worth of $4.94 million as of July 2, 2024. Its market cap has decreased by -94.11% in one year.
Market Cap
4.94M
Enterprise Value
5.31M
1-Year Change
-94.11%
Ranking
n/a
Category
Stock Price
$0.35
Market Cap Chart
Since October 30, 2014, BioSig Technologies's market cap has decreased from $35.30M to $4.94M, a decrease of -85.99%. That is a compound annual growth rate of -18.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2024 | 5.90M | -85.92% |
| Dec 29, 2023 | 41.90M | 107.43% |
| Dec 30, 2022 | 20.20M | -74.33% |
| Dec 31, 2021 | 78.70M | -33.31% |
| Dec 31, 2020 | 118.00M | -10.13% |
| Dec 31, 2019 | 131.30M | 84.41% |
| Dec 31, 2018 | 71.20M | 74.51% |
| Dec 29, 2017 | 40.80M | 51.11% |
| Dec 30, 2016 | 27.00M | 34.33% |
| Dec 31, 2015 | 20.10M | -34.74% |
| Dec 31, 2014 | 30.80M | -12.75% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 861.62B |
| Novo Nordisk | 627.27B |
| UnitedHealth Group | 457.17B |
| Johnson & Johnson | 351.64B |
| Merck & Co. | 323.16B |
| AbbVie | 294.26B |
| AstraZeneca | 238.91B |
| Novartis AG | 208.44B |